Award: Abstract Award for Excellence in Clinical Trials
Name:Karsten Nysom
Abstract Number: CTNI-24
Presentation Title: Clinical activity and safety of the RAF inhibitor tovorafenib in patients with optic pathway gliomas in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study
Presentation Date: Friday, November 17, 2023
Presentation Time: 10:15 AM – 10:25 AM PT

Award: Abstract Award for Excellence in Healthcare Equity
Name: Orieta Celiku
Abstract Number: DISP-15
Presentation Title: Disparities in the Availability of Neuro-Oncology Clinical Trial Supporting Infrastructure in the United States
Presentation Date: Friday, November 17, 2023
Presentation Time: 10:45 AM – 10:55 AM PT

Award: Abstract Award for Excellence in Neurosurgery
Name: Akhil Kondepudi
Abstract Number: SURG-04
Presentation Title: Fast detection of glioma infiltration using label-free optical microscopy and deep neural networks
Presentation Date: Friday, November 17, 2023
Presentation Time: 10:45 AM – 10:55 AM PT

Award: Abstract Award for Excellence in Basic Science
Name: Karl Habashy
Abstract Number: DDEL-06
Presentation Title: Microglia repair the disrupted blood-brain barrier following low-intensity pulsed ultrasound through P2RY12 signaling
Presentation Date: Friday, November 17, 2023
Presentation Time: 2:50 PM – 3:00 PM PT

Award: Abstract Award for Excellence in Pediatric
Name: Evangeline R. Jackson
Abstract Number: EXTH-36
Presentation Title: Combining ONC201 and paxalisib for the treatment of diffuse midline glioma (DMG); the preclinical results underpinning the international Phase II clinical trial (NCT05009992)
Presentation Date: Friday, November 17, 2023
Presentation Time: 3:00 PM – 3:10 PM PT

Award: Abstract Award for Excellence in Neurohematology
Name: Lakshmi Nayak
Abstract Number: CTIM-37
Presentation Title: A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (PCNSL and SCNSL) 
Presentation Date: Friday, November 17, 2023
Presentation Time: 3:10 PM – 3:20 PM PT

Award: Abstract Award for Excellence in Radiation
Name: William C. Chen
Abstract Number: BIOM-55
Presentation Title: Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Presentation Date: Friday, November 17, 2023
Presentation Time: 3:20 PM – 3:30 PM PT

Award: Abstract Award for Excellence in Cancer Neuroscience
Name: Richard Drexler
Abstract Number: CNSC-25
Presentation Title: Neural signature of GBM exhibits synaptogenic and OPC-like features and independently predicts patient survival
Presentation Date: Saturday, November 18, 2023
Presentation Time: 7:15 AM – 7:25 AM PT

Award: Abstract Award for Excellence in Cancer Neuroscience
Name: Vardhaan Ambati
Abstract Number: CNSC-29
Presentation Title: NKCC1 signaling in glioblastoma regulates neuronal hyperexcitability through GABAergic tone
Presentation Date: Saturday, November 18, 2023
Presentation Time: 7:25 AM – 7:35 AM PT

Award: EANO Abstract Scholarship Award 
Name: Ashlee R. Loughan
Abstract Number: QOL-20
Presentation Title: Including Brain Metastases Patients in Psychological Interventions: A Phase II Single-Arm Investigation of Managing Cancer and Living Meaningfully
Presentation Date: Saturday, November 18, 2023
Presentation Time: 7:25 AM – 7:35 AM PT

Award: Andrew Parsa (YI) Award
Name: Aparna Bhaduri
Abstract Number: STEM-11
Presentation Title: A glioblastoma single-cell meta-atlas identifies novel neurovascular progenitor in tumors
Presentation Date: Saturday, November 18, 2023
Presentation Time: 7:35 AM – 7:45 AM PT

Award: Abstract Award for Excellence in CNS Metastases
Name: Debarati Bhanja
Abstract Number: IMMU-02
Presentation Title: Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation
Presentation Date: Saturday, November 18, 2023
Presentation Time: 10:45 AM – 10:55 AM PT

Award: Abstract Award for Excellence in Neurology of Cancer
Name: Michel Friedrich
Abstract Number: NCOG-04
Presentation Title: Whole-brain structural connectivity predicts cognitive deficits in pretreated patients with CNS WHO grade 3 or 4 gliomas
Presentation Date: Saturday, November 18, 2023
Presentation Time: 10:45 AM – 10:55 AM PT

Award: Abstract Award for Excellence in CNS Metastases
Name: Emma K. Rigg
Abstract Number: TMIC-47
Presentation Title: Inhibition of miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes
Presentation Date: Saturday, November 18, 2023
Presentation Time: 11:35 AM – 11:45 AM PT

Award: Abstract Award for Excellence in Neurology of Cancer
Name: Francesco Bruno
Abstract Number: NCOG-22
Presentation Title: Seizure outcome across disease trajectory in IDH-mutant grade 2 gliomas: which is the impact of standard antineoplastic treatments?
Presentation Date: Saturday, November 18, 2023
Presentation Time: 11:35 AM – 11:45 AM PT

Award: Abstract Award for Excellence in Survivorship
Name: Christina Weyer Jamora
Abstract Number: QOL-25
Presentation Title: For the love of work: Novel study of vocational cognitive rehabilitation in primary brain tumor
Presentation Date: Saturday, November 18, 2023
Presentation Time: 2:30 PM – 2:40 PM PT

Award: Abstract Award for Excellence in Basic Science
Name: Jenna K. Minami
Abstract Number: TMET-12
Presentation Title: CDKN2A Deletion Remodels Lipid Metabolism to Prime Glioblastoma for Ferroptosis
Presentation Date: Saturday, November 18, 2023
Presentation Time: 3:45 PM – 3:55 PM PT

Award: Abstract Award for Excellence in CNS Rare Disease
Name: Priscilla K. Brastianos
Abstract Number: CTNI-73
Presentation Title: Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas
Presentation Date: Saturday, November 18, 2023
Presentation Time: 3:45 PM – 3:55 PM PT

Award: Abstract Award for Excellence in Neurogenetic Tumor Syndromes
Name: Scott R. Plotkin
Abstract Number: CTNI-80
Presentation Title: INTUITT-NF2, an adaptive platform-basket trial for NF2-related schwannomatosis patients with progressive schwannomas, meningiomas, and ependymomas: primary outcome of the brigatinib treatment arm
Presentation Date: Saturday, November 18, 2023
Presentation Time: 3:55 PM – 4:05 PM PT

Award: Abstract Award for Excellence in Molecular Pathology
Name: Erik A. Williams
Abstract Number: PATH-02
Presentation Title: Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs
Presentation Date: Sunday, November 19, 2023
Presentation Time: 8:30 AM – 8:40 AM PT

Award: Abstract Award for Excellence in Neuro-imaging
Name: Jacob Ellison
Abstract Number: NIMG-12
Presentation Title: Spatially mapping treatment-effect in recurrent glioma with physiologic MRI and deep learning
Presentation Date: Sunday, November 19, 2023
Presentation Time: 8:40 AM – 8:50 AM PT

Award: EANO Abstract Scholarship Award
Name: Fulvio D'Angelo
Abstract Number: EPCO-35
Presentation Title: Identification of diverse immune phenotypes in NF-1 glioma by single nuclei gene expression analysis
Presentation Date: Sunday, November 19, 2023
Presentation Time: 9:00 AM – 9:10 AM PT

Electronic Poster Awards